Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Grover

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Life Sciences|January 1, 1994
Role of endothelin receptor subtype B (ET-B) in myocardial ischemiaC A Sargent, E C Liu, C C Chao, et al.
Cardiovascular Research|January 1, 1995
Endogenous catecholamines are not necessary for ischaemic preconditioning in the isolated perfused rat heartE O Weselcouch, A J Baird, P G Sleph, et al.
Analytical Biochemistry|March 1, 1994
Characterization of rabbit myocardial phospholipase A2 activity using endogenous phospholipid substratesO Vesterqvist, C A Sargent, G J Grover, et al.
Cardiovascular Research|June 1, 1994
Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemiaA J D'Alonzo, R B Darbenzio, T A Hess, et al.
Cardiovascular Research|February 1, 1996
Glyburide-reversible cardioprotective effects of calcium-independent phospholipase A2 inhibition in ischemic rat heartsC A Sargent, M W Wilde, S Dzwonczyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotidesG J Grover, J Newburger, P G Sleph, et al.
Analytical Biochemistry|July 1, 1992
Quantitation of lysophosphatidylcholine molecular species in rat cardiac tissueO Vesterqvist, C A Sargent, S C Taylor, et al.
Journal of Cardiovascular Pharmacology|August 1, 1995
Pharmacologic profile of the dihydropyrimidine calcium channel blockers SQ 32,547 and SQ 32,926 [correction of SQ 32,946]G J Grover, S Dzwonczyk, D M McMullen, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channelC A Sargent, P G Sleph, S Dzwonczyk, et al.
Journal of Medicinal Chemistry|August 18, 1995
Cardioselective anti-ischemic ATP-sensitive potassium channel openers. 3. Structure-activity studies on benzopyranyl cyanoguanidines: modification of the cyanoguanidine portionK S Atwal, G J Grover, S Z Ahmed, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Life Sciences|January 1, 1994
Role of endothelin receptor subtype B (ET-B) in myocardial ischemiaC A Sargent, E C Liu, C C Chao, et al.
Cardiovascular Research|January 1, 1995
Endogenous catecholamines are not necessary for ischaemic preconditioning in the isolated perfused rat heartE O Weselcouch, A J Baird, P G Sleph, et al.
Analytical Biochemistry|March 1, 1994
Characterization of rabbit myocardial phospholipase A2 activity using endogenous phospholipid substratesO Vesterqvist, C A Sargent, G J Grover, et al.
Cardiovascular Research|June 1, 1994
Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemiaA J D'Alonzo, R B Darbenzio, T A Hess, et al.
Cardiovascular Research|February 1, 1996
Glyburide-reversible cardioprotective effects of calcium-independent phospholipase A2 inhibition in ischemic rat heartsC A Sargent, M W Wilde, S Dzwonczyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotidesG J Grover, J Newburger, P G Sleph, et al.
Analytical Biochemistry|July 1, 1992
Quantitation of lysophosphatidylcholine molecular species in rat cardiac tissueO Vesterqvist, C A Sargent, S C Taylor, et al.
Journal of Cardiovascular Pharmacology|August 1, 1995
Pharmacologic profile of the dihydropyrimidine calcium channel blockers SQ 32,547 and SQ 32,926 [correction of SQ 32,946]G J Grover, S Dzwonczyk, D M McMullen, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channelC A Sargent, P G Sleph, S Dzwonczyk, et al.
Journal of Medicinal Chemistry|August 18, 1995
Cardioselective anti-ischemic ATP-sensitive potassium channel openers. 3. Structure-activity studies on benzopyranyl cyanoguanidines: modification of the cyanoguanidine portionK S Atwal, G J Grover, S Z Ahmed, et al.
Pageof 13